The higher numbers of non BC-related deaths in the surveillance group seem to be coincidental, but may explain the higher overall mortality rate though comparable breast cancer-specific mortality rate among BRCA2 mutation carriers under surveillance. Here, BRCA2 is linked to breast carcinoma.